OnKure Therapeutics, Inc.
OKUR
$3.99
$0.092.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.35M | -15.16M | -13.50M | -14.70M | -15.39M |
| Total Depreciation and Amortization | 188.00K | 203.00K | 202.00K | 204.00K | 212.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.02M | 2.78M | 3.02M | 2.96M | 2.91M |
| Change in Net Operating Assets | 1.79M | -764.00K | -1.23M | -1.51M | -1.00M |
| Cash from Operations | -10.35M | -12.94M | -11.51M | -13.04M | -13.27M |
| Capital Expenditure | -3.00K | -5.00K | -9.00K | -6.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.87M | -- | -- | -- | -- |
| Cash from Investing | -9.87M | -5.00K | -9.00K | -6.00K | -13.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.20M | 146.00M | 240.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.58M | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -5.38M | 146.00M | 240.00K | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.60M | 133.06M | -11.28M | -13.04M | -13.29M |